13.Other Charges

The components of Other Charges were as follows (in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Professional fees incurred in connection with internal investigation	$	0.3	$	0.7	$	3.1	$	5.3
Acquisition-related charges	1.2		1.1		2.1		1.6
Information technology transformation costs	1.1		—		2.4		—
Restructuring charges	2.8		8.6		7.0		13.6
Long-lived asset impairments	6.9		—		6.9		—
Factory relocation costs	—		0.1		—		0.6
Other charges	$	12.3	$	10.5	$	21.5	$	21.1

Beginning in the fourth quarter of 2012 and continuing in 2013 and 2014, the Company commenced productivity improvement initiatives at both BSI and BEST in an effort to better optimize its operations. These restructuring initiatives include the divestiture of certain non-core businesses, outsourcing of various manufacturing activities, transferring or ceasing operations at certain facilities and an overall right-sizing within the Company based on the then current business environments.

The Company recorded total restructuring charges during the three and nine months ended September 30, 2014 of $16.2 million and $29.3 million, respectively, related to these initiatives, all within BSI. For the three months ended September 30, 2014, the charges consisted of $10.1 million of inventory provisions for excess inventory, $4.1 million of severance costs and $2.0 million of exit related costs, such as professional service and facility exit charges. For the nine months ended September 30, 2014, the charges consisted of $12.1 million of inventory provisions for excess inventory, $11.3 million of severance costs and $5.9 million of exit related costs. During the three and nine months ended September 30, 2014, the Company has recorded restructuring charges of $13.4 million and $22.3 million, respectively, as a component of Cost of Revenue and $2.8 million and $7.0 million, respectively, as a component of Other Charges in the accompanying condensed consolidated statement of income and comprehensive income.

In July 2014, the Company’s Board of Directors approved a plan (the Plan) to divest certain assets and implement a restructuring program in the CAM division within the Bruker CALID Group. The Plan was developed as a result of management’s conclusion that the CAM business would be unable to achieve acceptable financial performance in the next two years. Divestment and restructuring actions in connection with the Plan are expected to result in a reduction of CAM’s employee headcount by approximately 200 people. Restructuring and other one-time charges in connection with the Plan through the first half of 2015, including costs recorded in the third of quarter of 2014, are expected to be between $25 and $30 million, of which $8 to $11 million relate to employee separation and facility exit costs, and $17 to $19 million are estimated for inventory write-downs and asset impairments. The current expected restructuring and other one-time charges in connection with the Plan are lower than previously announced due to divestiture activity noted below.

Included in the total restructuring charges discussed above are restructuring expenses recorded during the third quarter of 2014 specifically related to the Plan of $13.1 million, consisting of $10.1 million for inventory write-downs and $3.0 million of severance and exit costs, of which $11.1 was recorded as a component of Cost of Revenue and $2.0 million as a component of Other Charges, net in the accompanying condensed consolidated statement of income and comprehensive income. The Company determined the approval of the Plan was an indicator requiring the evaluation of the long-lived assets, which included property, plant and equipment and definite-lived intangible assets, within the CAM division for recoverability. The Company performed a valuation during the three months ended September 30, 2014 and determined that certain long-lived assets were impaired. The Company recorded an impairment charge of $6.9 million in the three and nine months ended September 30, 2014, consisting of $5.5 million of property, plant and equipment, and $1.4 million of definite-lived intangible assts. This impairment charge is included as a component of Other Charges in the accompanying condensed consolidated statement of income and comprehensive income.

In addition, in September 2014 the Company divested the assets of the CAM division’s Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) product line. The gain on sale of the product line of $8.7 million has been recorded as part of Interest and Other Income (Expense), net within the accompanying condensed consolidated statement of income and comprehensive income.

Please see Note 17 — Subsequent Events, for information regarding activity subsequent to September 30, 2014 related to the Plan.

The following table sets forth the changes in the restructuring reserves for the nine months ended September 30, 2014 (in millions):

	Total			Provisions for Excess Inventory			Severance			Exit Costs
Balance at December 31, 2013	$	11.5		$	2.0		$	8.4		$	1.1
Restructuring charges	29.3			12.1			11.3			5.9
Cash payments	(16.1		)	(0.1		)	(10.0		)	(6.0		)
Non-cash adjustments	(3.9		)	(2.2		)	(1.4		)	(0.3		)
Foreign currency effect	(0.8		)	(0.1		)	(0.6		)	(0.1		)
Balance at September 30, 2014	$	20.0		11.7			$	7.7		$	0.6